- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic treatment for advanced pancreatic cancer
Authors
Keywords
-
Journal
World Journal of Gastrointestinal Oncology
Volume 15, Issue 10, Pages 1691-1705
Publisher
Baishideng Publishing Group Inc.
Online
2023-10-09
DOI
10.4251/wjgo.v15.i10.1691
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis
- (2023) Fausto Petrelli et al. BMC GASTROENTEROLOGY
- Treatment Costs and Social Burden of Pancreatic Cancer
- (2023) Elżbieta Cipora et al. Cancers
- Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation
- (2022) Maria Teresa Vietri et al. Genes
- Proteasome regulators in pancreatic cancer
- (2022) Nirosha J Murugan et al. World Journal of Gastrointestinal Oncology
- Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial
- (2022) Kim A Reiss et al. LANCET ONCOLOGY
- Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy
- (2022) Jin Wang et al. Frontiers in Immunology
- Familial Pancreatic Cancer
- (2022) Helena Saba et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases
- (2022) Alice Tison et al. Nature Reviews Rheumatology
- The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma
- (2022) Daniel J. Renouf et al. Nature Communications
- The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
- (2022) Qing Tang et al. Frontiers in Immunology
- GI Symptoms in Pancreatic Cancer
- (2022) Victor T. Chang et al. Clinical Colorectal Cancer
- Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update
- (2022) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
- (2021) Alison P. Klein Nature Reviews Gastroenterology & Hepatology
- Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial
- (2021) Bruno Bockorny et al. CLINICAL CANCER RESEARCH
- Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis
- (2021) Cecilia C. Ayala-Aguilera et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inherited Pancreatic Cancer Syndromes and High-Risk Screening
- (2021) Leah H. Biller et al. Surgical Oncology Clinics of North America
- Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
- (2021) Ahyeon Kim et al. Nutrients
- Early detection of pancreatic cancer
- (2020) Stephen P Pereira et al. Lancet Gastroenterology & Hepatology
- Pembrolizumab for the treatment of programmed death–ligand 1‒positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE‐028 study
- (2020) Janice M. Mehnert et al. CANCER
- BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
- (2020) Bruno Bockorny et al. NATURE MEDICINE
- Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers
- (2020) Oliver Klein et al. CLINICAL CANCER RESEARCH
- Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial
- (2020) Yang Liu et al. CYTOTHERAPY
- Evaluation of targetable biomarkers for chimeric antigen receptor T-cell (CAR-T) in the treatment of pancreatic cancer: a systematic review and meta-analysis of preclinical studies
- (2020) Maryam Sahlolbei et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results
- (2020) M. Sinn et al. EUROPEAN JOURNAL OF CANCER
- A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects with Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
- (2020) D Brock Hewitt et al. ANNALS OF SURGERY
- Broadening the impact of immunotherapy to pancreatic cancer: Challenges and opportunities
- (2019) Vinod P. Balachandran et al. GASTROENTEROLOGY
- Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
- (2019) Kyung Hae Jung et al. CLINICAL CANCER RESEARCH
- Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression
- (2019) Zhang Li et al. CARCINOGENESIS
- A randomized Phase 2b study of GVAX pancreas and CRS-207 compared to chemotherapy in previously-treated metastatic pancreatic adenocarcinoma patients (ECLIPSE Study)
- (2019) Dung T. Le et al. CLINICAL CANCER RESEARCH
- Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- (2019) Eileen M. O’Reilly et al. JAMA Oncology
- A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors
- (2019) Toshihiko Doi et al. CLINICAL CANCER RESEARCH
- Healthy lifestyle and the risk of pancreatic cancer in the EPIC study
- (2019) Sabine Naudin et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study
- (2019) Suneel D. Kamath et al. ONCOLOGIST
- Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis
- (2019) Kelvin K. W. Chan et al. Cancer Medicine
- The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Akram Pourshams et al. Lancet Gastroenterology & Hepatology
- WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study
- (2018) ANTICANCER RESEARCH
- Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
- (2018) Gregory L. Beatty et al. GASTROENTEROLOGY
- Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update
- (2018) Davendra P.S. Sohal et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers
- (2018) V. Chung et al. Clinical & Translational Oncology
- The Potential of CAR T Cell Therapy in Pancreatic Cancer
- (2018) Mehmet Akce et al. Frontiers in Immunology
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
- (2018) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunotherapy of cancers comes of age
- (2017) Hila Yousefi et al. Expert Review of Clinical Immunology
- Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
- (2017) Glen J. Weiss et al. INVESTIGATIONAL NEW DRUGS
- Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
- (2017) Shikhar Mehrotra et al. Journal of Hematology & Oncology
- CAR T-cell therapy for pancreatic cancer
- (2017) Carl J. DeSelm et al. JOURNAL OF SURGICAL ONCOLOGY
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
- (2017) Kaichao Feng et al. Protein & Cell
- Immune Checkpoint Inhibitors: Basics and Challenges
- (2017) Bin Li et al. CURRENT MEDICINAL CHEMISTRY
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
- (2016) Mark O'Hara et al. Immunotherapy
- Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors
- (2016) Hidenori Mizugaki et al. INVESTIGATIONAL NEW DRUGS
- Symptoms of Pancreatic Cancer in Primary Care
- (2016) Mia Schmidt-Hansen et al. PANCREAS
- HDACs and HDAC Inhibitors in Cancer Development and Therapy
- (2016) Yixuan Li et al. Cold Spring Harbor Perspectives in Medicine
- Advances in Cancer Immunotherapy in Solid Tumors
- (2016) Smitha Menon et al. Cancers
- Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN)
- (2015) V. Rebours et al. CLINICAL CANCER RESEARCH
- Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
- (2015) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
- (2014) M. Aglietta et al. ANNALS OF ONCOLOGY
- Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer
- (2014) Moon Jae Chung et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- p53MVA Therapy in Patients with Refractory Gastrointestinal Malignancies Elevates p53-Specific CD8+ T-cell Responses
- (2014) N. R. Hardwick et al. CLINICAL CANCER RESEARCH
- A Novel Chimeric Antigen Receptor Against Prostate Stem Cell Antigen Mediates Tumor Destruction in a Humanized Mouse Model of Pancreatic Cancer
- (2014) Daniel Abate-Daga et al. HUMAN GENE THERAPY
- Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients
- (2014) CAROLINE STAFF et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
- (2014) Gary Middleton et al. LANCET ONCOLOGY
- Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
- (2014) E. R. Lutz et al. Cancer Immunology Research
- Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort
- (2013) Rachael Z Stolzenberg-Solomon et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer
- (2013) Paolo G. Gobbi et al. Cancer Epidemiology
- Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer
- (2013) Dung T. Le et al. JOURNAL OF IMMUNOTHERAPY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
- (2012) A. Gonçalves et al. ANNALS OF ONCOLOGY
- Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study
- (2012) Jeffrey M. Hardacre et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Approval Summary: Sunitinib for the Treatment of Progressive Well-Differentiated Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
- (2012) G. M. Blumenthal et al. ONCOLOGIST
- An International Multicenter Randomized Controlled Trial of G17DT in Patients With Pancreatic Cancer
- (2012) Andrew D. Gilliam et al. PANCREAS
- A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma
- (2011) Lutz Eric et al. ANNALS OF SURGERY
- A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
- (2011) D. T. Le et al. CLINICAL CANCER RESEARCH
- A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer
- (2011) A. B. El-Khoueiry et al. INVESTIGATIONAL NEW DRUGS
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Immunologic Evaluation of Dendritic Cell–Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma
- (2011) Yukino Kimura et al. PANCREAS
- Engineered Tcells for pancreatic cancer treatment
- (2011) Usha L. Katari et al. HPB
- Targeting Mutated K-ras in Pancreatic Adenocarcinoma Using an Adjuvant Vaccine
- (2010) Ghassan K. Abou-Alfa et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
- (2010) Synne Wedén et al. INTERNATIONAL JOURNAL OF CANCER
- Genetic Mutations Associated with Cigarette Smoking in Pancreatic Cancer
- (2009) A. Blackford et al. CANCER RESEARCH
- Risk of Pancreatic Cancer in Families With Lynch Syndrome
- (2009) Fay Kastrinos JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started